Insights by Tag:

DLB

Market Reviews
South Korea Market Review, December 2024: principal-protected ELB sales spike as investors flock into retirement...

09 Jan 2025

South Korea Market Review, December 2024: principal-protected ELB sales spike as investors flock into retirement...

Sales of principal-protected equity-linked bonds continue to skyrocket at year-end while capital-at-risk equity-linked securities drop.

Market Reviews
South Korea Market Review, September 2024: sales rebound despite YoY drop

15 Oct 2024

South Korea Market Review, September 2024: sales rebound despite YoY drop

Sales rebound MoM as household names lead the pack. Autocallable sales recover following massive drop in August.

Market Reviews
South Korea Market Review, July 2024: sales rebound highest since January, Hyundai Motor roars

19 Aug 2024

South Korea Market Review, July 2024: sales rebound highest since January, Hyundai Motor roars

ELS sales slowly recovered MoM. The fully-principal-protected equity-linked bonds tracking Hyundai Motor stock gained visibility in July.

Products
FX-linked DLS, DLB gain traction in Korea

29 Jul 2024

FX-linked DLS, DLB gain traction in Korea

In the first half of the year, sales volume of FX rates-linked structured products soared over 7,000% year-on-year in South Korea.

Market Reviews
South Korea Market Review, May 2024: autocall sales bounce back, ELS volume soars by 60%

24 Jun 2024

South Korea Market Review, May 2024: autocall sales bounce back, ELS volume soars by 60%

Korea’s autocallable sales continue to show signs of recovery after they recorded a two-month increase in a row. Shinhan Investment leads sales; the Kospi 200 took over the Eurostoxx 50.

Market Reviews
South Korea Market Review, April 2024: ELB, DLB sales rebound as capital protection lures investors

03 Jun 2024

South Korea Market Review, April 2024: ELB, DLB sales rebound as capital protection lures investors

The Korean market continues to see investors pivoting from ELS to ELB and DLB products; Hana Securities’ overall structured product sales amounted to 24% market share in April.

Products
Samsung Securities: ELS shortcomings have shifted product activity

16 May 2024

Samsung Securities: ELS shortcomings have shifted product activity

The analyst at the Korean securities house says that while the issuance of recently embattled equity-linked securities (ELS) tied to the performance of HSCEI is expected to recover in the long run, the market participants may pivot their attention to ELS tracking those stock indices of other advanced markets, such as US, Europe, and Japan.

Market Reviews
South Korea Market Review, March 2024: Sales fall to 17-month low, HSCEI ELS woes drag on

25 Apr 2024

South Korea Market Review, March 2024: Sales fall to 17-month low, HSCEI ELS woes drag on

As the shockwaves of the H share index-linked ELS losses rattle the market, market participants’ attention has started to shift to capital-protected products.

Regulation
Korea court clears Hana Bank chair for mis-selling DLF penalty

06 Mar 2024

Korea court clears Hana Bank chair for mis-selling DLF penalty

The latest ruling overturns the first trial’s ruling in March 2022, which dismissed the bank’s then-CEO and other executives’ pledge to clear out the penalty for the DLF fiasco.

Products
Korea’s DLS issuance remains tepid

02 Feb 2024

Korea’s DLS issuance remains tepid

Interest rates continuously dominate as the most popular underlying assets for DLS and DLBs’ issuances in 2023.

Market Reviews
South Korea Market Review, December 2023: sales double MoM, five banks halt HSCEI-linked sales

26 Jan 2024

South Korea Market Review, December 2023: sales double MoM, five banks halt HSCEI-linked sales

There were 2,010 products issued in the retail segment in December.

Market Reviews
South Korea Market Review, October 2023: sales up 43% YoY, new counterparty enters the market

16 Nov 2023

South Korea Market Review, October 2023: sales up 43% YoY, new counterparty enters the market

There were 2,128 products issued in the retail segment in October.